Index of reports
> Cases with Platelet Count Decreased (519)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Revlimid (Lenalidomide) where reactions include platelet count decreased. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 519 Next >>
Possible Revlimid side effects in female
Reported by a physician from Japan on 2012-08-23
Patient: female
Reactions: Back Pain, Pain in Extremity, Anaemia, Bone Pain, Urinary Tract Infection, Gastrointestinal Candidiasis, Pyrexia, Liver Disorder, Diplopia, Face Oedema, Platelet Count Decreased, Lymphocyte Count Decreased
Drug(s) suspected as cause:
Aspirin
Dosage: 100 milligram
Administration route: Oral
Indication: Prophylaxis
Start date: 2010-11-15
Dexamethasone Acetate
Dosage: 40 milligram
Administration route: Oral
Start date: 2011-01-12
End date: 2011-01-14
Dexamethasone Acetate
Dosage: 40 milligram
Administration route: Oral
Start date: 2011-02-23
End date: 2011-02-24
Dexamethasone Acetate
Dosage: 40 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-11-15
End date: 2010-11-15
Dexamethasone Acetate
Dosage: 40 milligram
Administration route: Oral
Start date: 2011-02-02
End date: 2011-02-04
Dexamethasone Acetate
Dosage: 40 milligram
Administration route: Oral
Start date: 2011-03-30
End date: 2011-04-01
Dexamethasone Acetate
Dosage: 40 milligram
Administration route: Oral
Start date: 2011-04-20
End date: 2011-06-15
Dexamethasone Acetate
Dosage: 40 milligram
Administration route: Oral
Start date: 2011-03-07
End date: 2011-03-09
Dexamethasone Acetate
Dosage: 40 milligram
Administration route: Oral
Start date: 2010-11-30
End date: 2010-12-07
Dexamethasone Acetate
Dosage: 40 milligram
Administration route: Oral
Start date: 2010-12-22
End date: 2010-12-25
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-04-20
End date: 2011-05-10
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-11-15
End date: 2010-11-23
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-02-23
End date: 2011-03-15
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-06-08
End date: 2011-06-21
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-03-24
End date: 2011-04-13
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-01-26
End date: 2011-02-16
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-05-18
End date: 2011-05-31
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-07-13
End date: 2011-08-22
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2010-12-29
End date: 2011-01-25
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2010-11-30
End date: 2010-12-20
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-06-22
End date: 2011-07-05
Other drugs received by patient: Lendormin D; Sulfamethoxazole and Trimethoprim; Loxonin; Zometa; Famotidine; Risedronate Sodium; Risedronate Sodium; Loxonin; MS Reishippu; Maglax; Ketoprofen; Ketoprofen; Acetaminophen; Pursennid; Sulfamethoxazole and Trimethoprim; Sulfamethoxazole and Trimethoprim
Possible Revlimid side effects in male
Reported by a physician from Japan on 2012-08-23
Patient: male
Reactions: Performance Status Decreased, Back Pain, Nasopharyngitis, Pain in Extremity, Anaemia, Upper Respiratory Tract Inflammation, Rash, Delirium, Constipation, Upper Respiratory Tract Infection, Platelet Count Decreased, Urinary Retention, Neutropenia, Decreased Appetite
Drug(s) suspected as cause:
Dexamethasone Acetate
Dosage: 40 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-03
End date: 2010-12-03
Dexamethasone Acetate
Dosage: 40 milligram
Administration route: Oral
Start date: 2010-12-10
End date: 2010-12-10
Dexamethasone Acetate
Dosage: 40 milligram
Administration route: Oral
Start date: 2011-01-05
End date: 2011-01-06
Dexamethasone Acetate
Dosage: 40 milligram
Administration route: Oral
Start date: 2011-03-02
End date: 2011-03-05
Dexamethasone Acetate
Dosage: 40 milligram
Administration route: Oral
Start date: 2010-12-15
End date: 2010-12-15
Dexamethasone Acetate
Dosage: 40 milligram
Administration route: Oral
Start date: 2011-02-02
End date: 2011-02-03
Dexamethasone Acetate
Dosage: 40 milligram
Administration route: Oral
Start date: 2011-03-30
End date: 2011-03-31
Revlimid
Dosage: 10 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-03
End date: 2010-12-23
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-01-05
End date: 2011-01-18
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-02-02
End date: 2011-02-15
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-03-30
End date: 2011-04-13
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-06-22
End date: 2011-06-27
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-06-08
End date: 2011-06-13
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-03-02
End date: 2011-03-15
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-05-25
End date: 2011-05-31
Other drugs received by patient: Urief; Leuprolide Acetate; Leuprolide Acetate; Famotidine; Myser; Maglax; Urief; Lasix; Primperan TAB; Hokunalin:tape; Lansoprazole; Lansoprazole; Lendormin D; Hokunalin:tape; Spiriva; Ensure; Hokunalin:tape; Allopurinol; Propeto; Urief; Spiriva; Spiriva; Aspirin; Aspirin; Aricept; Zinc Oxide Simple Ointment; Maglax; Aricept; Lendormin D; Ciprofloxacin HCL; Casodex
Possible Revlimid side effects in female
Reported by a pharmacist from United States on 2012-08-23
Patient: female
Reactions: Human Chorionic Gonadotropin Increased, Platelet Count Decreased
Drug(s) suspected as cause:
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2012-05-18
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2012-06-28
Revlimid
Dosage: 15 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2009-03-12
Possible Revlimid side effects in female
Reported by a physician from United States on 2012-08-20
Patient: female
Reactions: Neuroendocrine Carcinoma, Death, Platelet Count Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
Revlimid
Possible Revlimid side effects in 33 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20
Patient: 33 year old male, weighing 123.0 kg (270.6 pounds)
Reactions: Abdominal Pain, Weight Decreased, Blood Bilirubin Increased, Headache, Oesophagitis, Hypocalcaemia, Blood Creatinine Increased, Stomatitis, Hyperglycaemia, Hypotension, Small Intestinal Obstruction, Aspartate Aminotransferase Increased, Platelet Count Decreased, Rash Maculo-Papular, Neutrophil Count Decreased, Graft Versus Host Disease, Pain, Somnolence, Gastritis, Ileus, Dizziness, Sinusitis, Gastrooesophageal Reflux Disease, Renal Failure Acute, White Blood Cell Count Decreased, Vomiting, Nausea, Alanine Aminotransferase Increased, Atrial Fibrillation, Hyponatraemia, Facial Pain, Eye Pain, Hypophosphataemia, Syncope, Diarrhoea, Hypoalbuminaemia, Skin Infection, Sinus Tachycardia, Large Intestinal Haemorrhage
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Revlimid
Other drugs received by patient: Caspofungin Acetate
Possible Revlimid side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17
Patient: male, weighing 109.0 kg (239.7 pounds)
Reactions: Platelet Count Decreased, Bone Disorder
Drug(s) suspected as cause:
Revlimid
Dosage: 10 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-10-25
Zometa
Other drugs received by patient: Calcium with Vitamin D; Vitamin D; Avodart; Decadron Phosphate; Coumadin; Doxazosin Mesylate; Lasix
Possible Revlimid side effects in male
Reported by a physician from Japan on 2012-08-14
Patient: male
Reactions: Sepsis, Platelet Count Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone Acetate
Dosage: 40 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-06-28
End date: 2012-07-04
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-06-28
End date: 2012-07-04
Possible Revlimid side effects in female
Reported by a pharmacist from United States on 2012-08-14
Patient: female
Reactions: Death, Platelet Count Decreased, Joint Injury
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Revlimid
Other drugs received by patient: Prochlorperazine; Butalbital / Acetaminophen; Ondansetron; Prednisone TAB; Mirtazapine; Senna LAX; Fentanyl; Olanzapine; Dexamethasone; Lorazepam; Bupropion HCL; Prochlorperazine; Fentanyl; Aspirin; Metoprolol; Triamcinolone; Prednisone TAB; Hydromorphone Hydrochloride; Marinol; Q-PAP; Lexapro; Climara; Dronabinol; Lorazepam; Bupropion HCL; Climara; Climara
Possible Revlimid side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient: male, weighing 107.1 kg (235.7 pounds)
Reactions: Drug Dose Omission, Protein Urine Present, Contusion, Hyperglycaemia, Malaise, Fatigue, Renal Impairment, Insomnia, Platelet Count Decreased, Blood Test Abnormal
Drug(s) suspected as cause:
Dexamethasone
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2012-06-01
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-07-29
End date: 2011-09-29
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2011-11-25
End date: 2012-01-01
Other drugs received by patient: Multi-Vitamins; BEE Pollen; Amlodipine; Lisinopril; Eplerenone; Furosemide; Vitamin D; Pravastatin; Carvedilol; Omeprazole; Oxybutynin Chloride; Garlic; Warfarin Sodium; Coenzyme Q10; Ferrous Sulfate TAB; Fish OIL; Caltrate + D; Metformin Hydrochloride; Prolia
Possible Revlimid side effects in female
Reported by a physician from United States on 2012-08-10
Patient: female, weighing 60.0 kg (132.0 pounds)
Reactions: Platelet Count Decreased, Multiple Myeloma
Adverse event resulted in: death
Drug(s) suspected as cause:
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2011-08-01
End date: 2012-02-01
Revlimid
Dosage: 10 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-10-01
Other drugs received by patient: Sodium Chloride; Acetaminophen; Decadron Phosphate; Velcade
Possible Revlimid side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient: male
Reactions: White Blood Cell Count Decreased, Haemorrhage, Platelet Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Revlimid
Other drugs received by patient: Prochlorperazine Maleate; Hydrocortisone; Tylenol (Caplet)
Possible Revlimid side effects in female
Reported by a physician from United States on 2012-08-07
Patient: female
Reactions: Pneumonia, Platelet Count Decreased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2012-05-04
End date: 2012-07-19
Revlimid
Dosage: 2.5 milligram
Administration route: Oral
Start date: 2012-07-19
Other drugs received by patient: Platelets; Procrit; Procrit
Possible Revlimid side effects in female
Reported by a physician from Japan on 2012-08-07
Patient: female
Reactions: Hepatic Function Abnormal, Pain, Constipation, Multi-Organ Failure, Upper Respiratory Tract Infection, Hypoxia, Lymphocyte Count Decreased, Decreased Appetite, White Blood Cell Count Decreased, Pneumonia, LIP DRY, Restlessness, Anaemia, Cardiac Failure, Depressed Level of Consciousness, Platelet Count Decreased, Bronchitis, Neutrophil Count Decreased
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Dexamethasone Acetate
Dosage: 40 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-01-12
End date: 2011-01-12
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2010-12-01
End date: 2010-12-21
Revlimid
Dosage: 10 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-09-28
End date: 2010-10-20
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2011-01-05
End date: 2011-01-18
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2010-11-04
End date: 2010-11-23
Other drugs received by patient: Zometa; Decadron Phosphate; Depas; Aspirin; Risperdal; Zometa; Decadron Phosphate; Zometa; Omeprazole; Prednisolone; Prednisolone; Depas; Ventolin; Decadron Phosphate; Prednisolone; Decadron Phosphate; Decadron Phosphate; Famotidine
Possible Revlimid side effects in 65 year old male
Reported by a pharmacist from United States on 2012-08-07
Patient: 65 year old male
Reactions: Platelet Count Decreased, Thrombocytopenia
Drug(s) suspected as cause:
Armodafinil
Dosage: 400 mg, 1x/day
Indication: Product Used FOR Unknown Indication
Start date: 2010-05-01
Coumadin
Dosage: 2 mg, unk
Coumadin
Dosage: 2.5 mg, unk
End date: 2011-02-27
Revlimid
Dosage: 10 mg, 21 in 21 d
Administration route: Oral
Indication: Amyloidosis
Start date: 2011-01-01
Revlimid
Dosage: 15 mg, 1 in 1d
Administration route: Oral
Start date: 2011-02-01
End date: 2011-02-24
Revlimid
Dosage: 5 mg, 21 in 21 d
Administration route: Oral
Start date: 2011-08-01
Revlimid
Dosage: 10 mg, 1 in 1d
Administration route: Oral
Start date: 2011-06-07
End date: 2011-06-30
Revlimid
Dosage: 5 mg, 1 in 2 d
Administration route: Oral
Start date: 2012-04-01
End date: 2012-01-01
Other drugs received by patient: Phoslo; Lasix; Xanax; Coreg; Zoloft; Colace; Crestor; Cardura; Hydralazine; Dexamethasone
Possible Revlimid side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-03
Patient: male
Reactions: Haemorrhage, Platelet Count Decreased, Bone Marrow Failure, Sinusitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2011-01-01
Revlimid
Dosage: 25-15mg
Administration route: Oral
Start date: 2009-05-01
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2012-07-01
Revlimid
Dosage: 15 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2009-02-01
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2012-03-01
Possible Revlimid side effects in female
Reported by a physician from United States on 2012-08-01
Patient: female
Reactions: Sepsis, Platelet Count Decreased, Pancytopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2012-05-01
Revlimid
Dosage: 2.5 milligram
Administration route: Oral
Start date: 2012-07-01
Other drugs received by patient: Platelets
Possible Revlimid side effects in female
Reported by a physician from Belgium on 2012-07-30
Patient: female, weighing 62.6 kg (137.7 pounds)
Reactions: Anaemia, Febrile Neutropenia, Platelet Count Decreased, Pyrexia, Lung Squamous Cell Carcinoma Stage Unspecified
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Start date: 2012-07-02
Dexamethasone
Start date: 2012-07-03
Dexamethasone
Administration route: Oral
Start date: 2011-06-24
End date: 2011-07-20
Dexamethasone
Administration route: Oral
Start date: 2012-04-26
Dexamethasone
Start date: 2012-07-04
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Start date: 2012-05-31
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
End date: 2012-06-27
Dexamethasone
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-01-05
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2011-04-28
End date: 2011-06-16
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2012-01-05
End date: 2012-01-25
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2012-02-02
Revlimid
Administration route: Oral
Start date: 2011-02-03
End date: 2011-04-20
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-06-24
End date: 2011-12-28
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2012-04-26
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2012-05-31
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2012-05-30
End date: 2012-06-27
Revlimid
Dosage: 10 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-01-05
Other drugs received by patient: R Calm Creme; RED Blood Cells; Cetavlex; Flexium; Platelets; Polyethylene Glycol; Aspirin; Meropenem; Bisoprolol Fumarate; Flexium; Sodium Chloride; Symbicort; Cranberry Extract; Pantoprazole
Possible Revlimid side effects in male
Reported by a pharmacist from Canada on 2012-07-30
Patient: male
Reactions: Platelet Count Decreased, Arrhythmia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Revlimid
Dosage: 15 milligram
Administration route: Oral
Revlimid
Dosage: 15 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-29
Other drugs received by patient: Dexamethasone; Valtrex; Avodart; Sulfatrim-DS; Omeprazole
Possible Revlimid side effects in female
Reported by a pharmacist from United States on 2012-07-30
Patient: female
Reactions: Platelet Count Decreased, Joint Injury
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Revlimid
Possible Revlimid side effects in female
Reported by a physician from United States on 2012-07-27
Patient: female
Reactions: Death, Platelet Count Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2010-10-01
End date: 2011-01-01
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2011-06-03
End date: 2012-04-30
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2010-05-01
End date: 2010-01-01
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2011-07-01
End date: 2012-04-30
Possible Revlimid side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-25
Patient: male
Reactions: Haemorrhage, Platelet Count Decreased, Sinusitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Revlimid
Dosage: 15 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2009-02-01
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2012-03-01
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2011-01-01
Revlimid
Dosage: 25-15mg
Administration route: Oral
Start date: 2009-05-01
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2012-07-01
Possible Revlimid side effects in female
Reported by a physician from United States on 2012-07-19
Patient: female
Reactions: Death, Abasia, Platelet Count Decreased, Rash, Kidney Infection, Blood Glucose Increased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Revlimid
Possible Revlimid side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18
Patient: male
Reactions: White Blood Cell Count Decreased, Haemorrhage, Platelet Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Revlimid
Other drugs received by patient: Prochlorperazine Maleate; Tylenol (Caplet); Hydrocortisone
Possible Revlimid side effects in male
Reported by a physician from Japan on 2012-07-18
Patient: male
Reactions: Bronchopneumonia, Disseminated Intravascular Coagulation, Pyrexia, Constipation, Herpes Zoster, Neuropathy Peripheral, C-Reactive Protein Increased, Thrombocytopenia, Blood Creatinine Increased, Cardiac Failure Congestive, Decreased Appetite, Prothrombin Time Ratio Increased, Dyspnoea, Pneumonia, Anaemia, Muscular Weakness, Lobar Pneumonia, Haemoglobin Decreased, Cerebral Infarction, Sepsis, Platelet Count Decreased, Neutropenia, Neutrophil Count Decreased
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Start date: 2012-01-13
End date: 2012-02-03
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-12-10
End date: 2012-01-07
Prednisolone
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-05-12
End date: 2011-05-25
Prednisolone
Dosage: 60 milligram
Administration route: Oral
Start date: 2011-05-26
End date: 2011-06-01
Prednisolone
Dosage: 10 milligram
Indication: Multiple Myeloma
Start date: 2012-02-09
End date: 2012-02-17
Prednisolone
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-03-31
End date: 2011-04-13
Prednisolone
Dosage: 60 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-03-24
End date: 2011-03-30
Prednisolone
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-08-17
End date: 2012-02-08
Prednisolone
Dosage: 60 milligram
Administration route: Oral
Start date: 2011-04-21
End date: 2011-05-11
Revlimid
Dosage: 15 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-03-24
End date: 2011-04-13
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-08-17
End date: 2011-09-06
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-09-14
End date: 2011-10-03
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-10-12
End date: 2011-10-22
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-12-11
End date: 2011-12-31
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2011-04-21
End date: 2011-05-11
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2012-01-25
End date: 2012-02-11
Other drugs received by patient: Glufast; Warfarin Sodium; Famotidine; Mucosta; Flomax; Warfarin Sodium; Magnesium Oxide; Zometa; Lansoprazole; Magnesium Oxide; Slow-K; Glufast; Tamsulosin HCL; Humulin R; Warfarin Sodium; Tamsulosin HCL; SHA-Kanzo-TO; SHA-Kanzo-TO; Levothyroxine Sodium; Diovan; Slow-K; Warfarin Sodium; Mucosta; Diovan; Clarithromycin; Levothyroxine Sodium; Levothyroxine Sodium; Zometa
Possible Revlimid side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-17
Patient: female
Reactions: Haemoglobin Decreased, Renal Failure, Platelet Count Decreased, Atrial Fibrillation, Cardiac Failure Congestive
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Revlimid
Dosage: 2.5 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-09-12
Revlimid
Dosage: 1.4286 milligram
Administration route: Oral
Start date: 2012-02-01
End date: 2012-04-23
Other drugs received by patient: Aspirin; Cartia XT; Furosemide; Dexamethasone; Fenofibrate; Vitamin E; Carvedilol; Vicodin; Vitamin D; Allopurinol; Diovan; Gabapentin; Terazosin HCL; Vytorin; Humalog
Possible Revlimid side effects in female
Reported by a physician from United States on 2012-07-16
Patient: female, weighing 50.8 kg (111.7 pounds)
Reactions: Blood Calcium Decreased, Pneumonia, Platelet Count Decreased, Blood Magnesium Decreased, Clostridial Infection
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 mg, 1/week
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-06-06
Revlimid
Dosage: 25 mg, cyclic
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-06-05
Velcade
Dosage: unk
Indication: Multiple Myeloma
Start date: 2012-05-01
Velcade
Dosage: 0.1 mg, 1/week
Start date: 2012-06-05
Other drugs received by patient: Zometa
Possible Revlimid side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-12
Patient: female
Reactions: Haemoglobin Decreased, Platelet Count Decreased, Thrombocytopenia, Full Blood Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-06-01
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-06-01
Possible Revlimid side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-10
Patient:
Reactions: Confusional State, Hypoglycaemia, Blood Albumin Decreased, Acidosis, Prothrombin Time Prolonged, Blood Fibrinogen Decreased, Oedema Peripheral, Blood Creatinine Increased, Renal Failure Acute, White Blood Cell Count Decreased, Blood Alkaline Phosphatase Increased, International Normalised Ratio Increased, Hypotension, Haemoglobin Decreased, Sepsis, Platelet Count Decreased, Neutrophil Count Decreased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Decadron
Dosage: 20 mg, qw
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-07-31
End date: 2010-08-28
Decadron
Dosage: 12 mg, qd
Administration route: Oral
Start date: 2010-11-12
End date: 2010-11-15
Revlimid
Dosage: 25 mg, qd
Indication: Multiple Myeloma
Start date: 2010-08-15
Other drugs received by patient: Alkeran
Possible Revlimid side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-06
Patient: female
Reactions: Abasia, Platelet Count Decreased, Rash, Kidney Infection, Blood Glucose Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Revlimid
Possible Revlimid side effects in male
Reported by a physician from Japan on 2012-07-05
Patient: male
Reactions: Platelet Count Decreased, Neutropenia, Arrhythmia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone Acetate
Dosage: 4 milligram
Administration route: Oral
Start date: 2010-12-03
End date: 2010-12-06
Dexamethasone Acetate
Dosage: 40 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-11-25
End date: 2010-11-28
Dexamethasone Acetate
Dosage: 40 milligram
Administration route: Oral
Start date: 2010-12-21
End date: 2010-12-24
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2010-12-14
End date: 2011-01-03
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-01-25
End date: 2011-02-02
Revlimid
Dosage: 5 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-11-17
End date: 2010-12-07
Other drugs received by patient: Diflucan; NEO-Minophagen C; Polaramine; Lasix; Levofloxacin; Allopurinol; Lantus; Juvela; Vitamedin; Daiphen; Lansoprazole; Alfarol; Decadron; Sodium Bicarbonate; Aspirin; Vicclox; Novolin R; Precipitated Calcium Carbonate; Unasyn; Levofloxacin
Page 1 Next >>
|